Depression is one of the main risk factors for the cognitive impairment There are epidemiological, clinical, physiological, physiopathogenic, diagnostic, neurochemical, biomarker and therapeutic tests that prove the interrelated interrelation between both entities. The virtual course will analyze all these aspects.
The objective of this training is that the participants can study the cognitive deterioration in order to diagnose this problem; differentiate the stages and types of deterioration; and be able to go to different therapies to treat them.
At the end of the course, participants will be able to:
- Perform early and accurate diagnosis of cognitive impairment.
- Power to make the differential diagnosis with normal cognitive decline.
- Make early and accurate diagnosis of depression.
- Know the elements of differential diagnosis between normal decline, cognitive impairment, dementia and depression.
- Know the pharmacological and non-pharmacological therapeutic management of these entities.
The course consists of the following modules or sessions:
Depression and cognitive deterioration: medical, economic and social impact "", Dr. Raúl Arizaga
The evidences of the relationship depression - cognitive deterioration "", Dr. María Cecilia Fernández
The clinical look: risk factors or comorbidities? "" Dr. Fernando Taragano "
Three theoretical modules.
Final exam multiple choice.
The Virtual Course will serve as the base of knowledge for, then, in the Face-to-Face Course, to deepen in all the aspects covered in the three virtual presentations.
This course is aimed at neurologists, psychologists, geriatricians, neuroimaging specialists, laboratory biomarkers, neuropsychologists, speech pathologists, music therapists, and all types of professionals doctors and paramedics related to the problem of cognitive impairment, dementia and depression, its interrelation, its risk factors and its therapeutics.